BCA-1/BLC (CXCL13), human recombinant | 4001

Human BCA-1 (B Cell-Attracting chemokine 1), also known as BLC or CXCL13, is a recently identified new CXC chemokines. Human BCA-1 is a highly effective attractant for human blood B lymphocytes, but was inactive on freshly isolated or IL-2 stimulated T lymphocytes, monocytes and neutrophils. The human BCA-1 is a 10.1 kDa protein containing 85 amino acid residues.

4001 | BCA-1/BLC CXCL13 human recombinant DataSheet

Biomolecule/Target: BCA-1/BLC (CXCL13)

Synonyms: B cell Attracting Chemokine-1, CXCL13, BLC (mouse), BLR1 Ligand

Alternates names: Small inducible cytokine A19, CCL19, Macrophage inflammatory protein 3 , MIP-3- , EBI1-ligand chemokine, ELC, chemokine exodus-3, CK -11, chemokine (C-C motif) ligand 19, CKb11, MIP3B, MIP-3b, SCYA19, MGC34433, Beta-chemokine exodus-3, CK beta-11, Epstein-Barr virus-induced molecule 1 ligand chemokine

Taglines: A cytokine selectively chemotactic for B cells

NCBI Gene ID #: 6363

NCBI Gene Symbol: CCL19

Gene Source: Human

Accession #: Q99731

Recombinant: Yes

Source: E. coli

Purity by SDS-PAGEs: 99%

Assay: SDS-PAGE

Purity: 95%

Assay #2: HPLC

Endotoxin Level: <0.1 ng/g

Activity (Specifications/test method): N/A

Biological activity: Determined by its ability to chemoattract human T cells using a concentration range of 10-50 ng/ml.

Results: 1.0-10 ng/ml.

Binding Capacity: N/A

Unit Definition: N/A

Molecular Weight: 8.8 kDa

Concentration: N/A

Appearance: Lyophilized protein

Physical form description: Sterile filtered and lyophilized from 10 mM TFA

Reconstitution Instructions: Reconstitute in HO to a concentration of 0.1-1.0 mg/ml. This solution can then be diluted into other aqueous buffers

Amino acid sequence: N/A